1. Home
  2. /
  3. Availability
  4. /
  5. Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis:

Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis:

Description

Uses a dynamic TB transmission model to estimate how the population impact of future TB vaccines changes depending on whether vaccines prevent progression to infectious symptomatic TB only, all infectious TB, or all TB disease.
TB vaccine theme
Availability
Epidemiological impact

Project details

Country
India
Timeline
2026
Target group
Adults
Vaccine
Hypothetical vaccines, M72/AS01e
Type of protection of vaccine
Prevention of disease
Type of research
Modelling
Partners involved
Aurum institute, BMGF, JHU, KNCV, LSHTM, SATVI, University of Cape Town, University of the Witwatersrand, Vanderbilt University
Type of project
research
Funder
BMGF
Civil Society
Governmental Body

Resources

Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study

Contact

Rebecca A. Clark
rebecca.clark@lshtm.ac.uk
Click to copy link of this header Menu